Feasibility of Intratumoral Anti-PD1 as Treatment of Human Basal Cell Carcinoma: An Explorative Study with Adjuvant Ablative Fractional Laser

Silje Haukali Omland(Frederiksberg Hospital), Merete Hædersdal(Frederiksberg Hospital)
Cancers
November 25, 2022
Cited by 13


Related Papers